worldwide offices | contact | help | sitemap | large text versionregular text version

Welcome to Novartis US

 

 

 

Investors

Welcome to Novartis Investor Relations for the United States. Novartis (NYSE: NVS), which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader in the research and development of products that protect and improve health and well-being. Its core businesses are in pharmaceuticals, vaccines, consumer health, generics, eye care, and animal health.

Sales & Reports

Our reports package consists of the following downloadable information as well as a webcast on our quarterly and full-year results.

US Investor Center

Information for investors on buying ADSs through Direct Purchase, material information on ADS proxy voting and Syngenta tax basis information.

Global Releases

Products & Pipelines

Presentations & Events

If you would like investor information, please contact:

Ronen Tamir
212-830-2433

Jill Pozarek
212-830-2445

Arun Nadiga
212-830-2444

Edwin Valeriano
212-830-2456

investor.relations@novartis.com

NYSE

SWX

 
 

NVS

 
 

NOVZn

ThinkWhatsPossible.com

NOVARTIS CUSTOMER CONNECTION